Viewing Study NCT00275912


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT00275912
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2006-01-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
Sponsor: Novartis
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-09-11
Start Date Type: ACTUAL
Primary Completion Date: 2007-09-28
Primary Completion Date Type: ACTUAL
Completion Date: 2007-09-28
Completion Date Type: ACTUAL
First Submit Date: 2006-01-11
First Submit QC Date: None
Study First Post Date: 2006-01-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-02-20
Last Update Post Date: 2017-02-23
Last Update Post Date Type: ACTUAL